Congenital protein c deficiency and myocardial infarction: Concomitant factor VII hyperactivity may play a role in the onset of arterial thrombosis
A 29-year-old man with congenital protein C deficiency and acute myocardial infarction is reported. Four hours after the onset of chest pain, he was treated intravenously with tissue-type plasminogen activator. Subsequent coronary angiography revealed only slight stenosis of the left anterior descen...
Gespeichert in:
Veröffentlicht in: | Thrombosis research 1992-07, Vol.67 (1), p.95-103 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 103 |
---|---|
container_issue | 1 |
container_start_page | 95 |
container_title | Thrombosis research |
container_volume | 67 |
creator | Kario, Kazuomi Matsuo, Takefumi Tai, Shigeru Sakamoto, Susumu Yamada, Tsutomu Miki, Takahiko Matsuo, Miyako |
description | A 29-year-old man with congenital protein C deficiency and acute myocardial infarction is reported. Four hours after the onset of chest pain, he was treated intravenously with tissue-type plasminogen activator. Subsequent coronary angiography revealed only slight stenosis of the left anterior descending coronary artery without any atherosclerosis. The propositus, his brother, and his mother, showed low levels of both protein C activity and antigen, while plasma thrombomodulin levels were normal. His grandfather had died from acute myocardial infarction at 38 years of age. We investigated several other risk factors for arterial thrombosis, including factor VII, fibrinogen, heparin cofactor II, lipoprotein (a), and anticardiolipin antibodies. No other haemostatic abnormalities apart from factor VI hyperactivity were detected in this family. To study the effects of protein C and factor VI on procoagulant activity, prothrombin time was measured after the addition of activated protein C and factor VI to protein C-deficient plasma. The prothrombin time ratio decreased along with an increase in the factor VII level. It also decreased with a decrease in the activated protein C level. These findings indicated that the procoagulant activity of factor VI was enhanced by low protein C levels, suggesting that concomitant factor VII hyper-activity may cause acute myocardial infarction in patients with protein C deficiency. |
doi_str_mv | 10.1016/0049-3848(92)90261-8 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_pubmed_primary_1440517</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>0049384892902618</els_id><sourcerecordid>73332155</sourcerecordid><originalsourceid>FETCH-LOGICAL-c452t-485d76f522d9f77b3dcfdc9424f42594ce0099e9e4f33a872e9aebe5de69ff693</originalsourceid><addsrcrecordid>eNp9kc2KFDEUhYMoY8_oGyhkITIuSvNbVZmFII0_DQNu1G1IJzd2pCppk_RAPYcvbHq6GXduEsL9zuHmHIReUPKWEtq_I0Sojo9ivFbsjSKsp934CK3oOKiOiYE9RqsH5Cm6LOUXIXSgSl6gCyoEkXRYoT_rFH9CDNVMeJ9ThRCxxQ58sAGiXbCJDs9Lsia70JgQvcm2hhRvcJPaNDdprNgbW1PGPzYbvFv2kNsz3IW64NkseD-1w-CcJmgGuO4Ap1ig4uSxyRXy0bnucpq3qYTyDD3xZirw_Hxfoe-fPn5bf-luv37erD_cdlZIVjsxSjf0XjLmlB-GLXfWO6sEE14wqYQFQpQCBcJzbsaBgTKwBemgV973il-h1yff9vHfByhVz6FYmCYTIR2KHjjnjErZQHECbU6lZPB6n8Ns8qIp0ccu9DFofQxaK6bvu9Bjk708-x-2M7h_olP4bf7qPDfFmslnE20oD5hsHfKeN-z9CYOWxV2ArMt9N-BCBlu1S-H_e_wF39CogA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>73332155</pqid></control><display><type>article</type><title>Congenital protein c deficiency and myocardial infarction: Concomitant factor VII hyperactivity may play a role in the onset of arterial thrombosis</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>Kario, Kazuomi ; Matsuo, Takefumi ; Tai, Shigeru ; Sakamoto, Susumu ; Yamada, Tsutomu ; Miki, Takahiko ; Matsuo, Miyako</creator><creatorcontrib>Kario, Kazuomi ; Matsuo, Takefumi ; Tai, Shigeru ; Sakamoto, Susumu ; Yamada, Tsutomu ; Miki, Takahiko ; Matsuo, Miyako</creatorcontrib><description>A 29-year-old man with congenital protein C deficiency and acute myocardial infarction is reported. Four hours after the onset of chest pain, he was treated intravenously with tissue-type plasminogen activator. Subsequent coronary angiography revealed only slight stenosis of the left anterior descending coronary artery without any atherosclerosis. The propositus, his brother, and his mother, showed low levels of both protein C activity and antigen, while plasma thrombomodulin levels were normal. His grandfather had died from acute myocardial infarction at 38 years of age. We investigated several other risk factors for arterial thrombosis, including factor VII, fibrinogen, heparin cofactor II, lipoprotein (a), and anticardiolipin antibodies. No other haemostatic abnormalities apart from factor VI hyperactivity were detected in this family. To study the effects of protein C and factor VI on procoagulant activity, prothrombin time was measured after the addition of activated protein C and factor VI to protein C-deficient plasma. The prothrombin time ratio decreased along with an increase in the factor VII level. It also decreased with a decrease in the activated protein C level. These findings indicated that the procoagulant activity of factor VI was enhanced by low protein C levels, suggesting that concomitant factor VII hyper-activity may cause acute myocardial infarction in patients with protein C deficiency.</description><identifier>ISSN: 0049-3848</identifier><identifier>EISSN: 1879-2472</identifier><identifier>DOI: 10.1016/0049-3848(92)90261-8</identifier><identifier>PMID: 1440517</identifier><identifier>CODEN: THBRAA</identifier><language>eng</language><publisher>New York, NY: Elsevier Ltd</publisher><subject>Acute myocardial infarction ; Adult ; Aged ; Aged, 80 and over ; Aspirin - therapeutic use ; Biological and medical sciences ; Blood Coagulation Factors - analysis ; Congenital protein C deficiency ; Factor VII - analysis ; Factor VII hyperactivity ; Hematology ; Humans ; Investigative techniques, diagnostic techniques (general aspects) ; Male ; Medical sciences ; Middle Aged ; Myocardial Infarction - blood ; Myocardial Infarction - drug therapy ; Myocardial Infarction - etiology ; Pathology. Cytology. Biochemistry. Spectrometry. Miscellaneous investigative techniques ; Pedigree ; Plasma thrombomodulin level ; Protein C Deficiency ; Prothrombin Time ; Risk Factors ; Thrombosis - etiology ; Tissue Plasminogen Activator - therapeutic use</subject><ispartof>Thrombosis research, 1992-07, Vol.67 (1), p.95-103</ispartof><rights>1992</rights><rights>1992 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c452t-485d76f522d9f77b3dcfdc9424f42594ce0099e9e4f33a872e9aebe5de69ff693</citedby><cites>FETCH-LOGICAL-c452t-485d76f522d9f77b3dcfdc9424f42594ce0099e9e4f33a872e9aebe5de69ff693</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/0049-3848(92)90261-8$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=5472363$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/1440517$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kario, Kazuomi</creatorcontrib><creatorcontrib>Matsuo, Takefumi</creatorcontrib><creatorcontrib>Tai, Shigeru</creatorcontrib><creatorcontrib>Sakamoto, Susumu</creatorcontrib><creatorcontrib>Yamada, Tsutomu</creatorcontrib><creatorcontrib>Miki, Takahiko</creatorcontrib><creatorcontrib>Matsuo, Miyako</creatorcontrib><title>Congenital protein c deficiency and myocardial infarction: Concomitant factor VII hyperactivity may play a role in the onset of arterial thrombosis</title><title>Thrombosis research</title><addtitle>Thromb Res</addtitle><description>A 29-year-old man with congenital protein C deficiency and acute myocardial infarction is reported. Four hours after the onset of chest pain, he was treated intravenously with tissue-type plasminogen activator. Subsequent coronary angiography revealed only slight stenosis of the left anterior descending coronary artery without any atherosclerosis. The propositus, his brother, and his mother, showed low levels of both protein C activity and antigen, while plasma thrombomodulin levels were normal. His grandfather had died from acute myocardial infarction at 38 years of age. We investigated several other risk factors for arterial thrombosis, including factor VII, fibrinogen, heparin cofactor II, lipoprotein (a), and anticardiolipin antibodies. No other haemostatic abnormalities apart from factor VI hyperactivity were detected in this family. To study the effects of protein C and factor VI on procoagulant activity, prothrombin time was measured after the addition of activated protein C and factor VI to protein C-deficient plasma. The prothrombin time ratio decreased along with an increase in the factor VII level. It also decreased with a decrease in the activated protein C level. These findings indicated that the procoagulant activity of factor VI was enhanced by low protein C levels, suggesting that concomitant factor VII hyper-activity may cause acute myocardial infarction in patients with protein C deficiency.</description><subject>Acute myocardial infarction</subject><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Aspirin - therapeutic use</subject><subject>Biological and medical sciences</subject><subject>Blood Coagulation Factors - analysis</subject><subject>Congenital protein C deficiency</subject><subject>Factor VII - analysis</subject><subject>Factor VII hyperactivity</subject><subject>Hematology</subject><subject>Humans</subject><subject>Investigative techniques, diagnostic techniques (general aspects)</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Myocardial Infarction - blood</subject><subject>Myocardial Infarction - drug therapy</subject><subject>Myocardial Infarction - etiology</subject><subject>Pathology. Cytology. Biochemistry. Spectrometry. Miscellaneous investigative techniques</subject><subject>Pedigree</subject><subject>Plasma thrombomodulin level</subject><subject>Protein C Deficiency</subject><subject>Prothrombin Time</subject><subject>Risk Factors</subject><subject>Thrombosis - etiology</subject><subject>Tissue Plasminogen Activator - therapeutic use</subject><issn>0049-3848</issn><issn>1879-2472</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1992</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kc2KFDEUhYMoY8_oGyhkITIuSvNbVZmFII0_DQNu1G1IJzd2pCppk_RAPYcvbHq6GXduEsL9zuHmHIReUPKWEtq_I0Sojo9ivFbsjSKsp934CK3oOKiOiYE9RqsH5Cm6LOUXIXSgSl6gCyoEkXRYoT_rFH9CDNVMeJ9ThRCxxQ58sAGiXbCJDs9Lsia70JgQvcm2hhRvcJPaNDdprNgbW1PGPzYbvFv2kNsz3IW64NkseD-1w-CcJmgGuO4Ap1ig4uSxyRXy0bnucpq3qYTyDD3xZirw_Hxfoe-fPn5bf-luv37erD_cdlZIVjsxSjf0XjLmlB-GLXfWO6sEE14wqYQFQpQCBcJzbsaBgTKwBemgV973il-h1yff9vHfByhVz6FYmCYTIR2KHjjnjErZQHECbU6lZPB6n8Ns8qIp0ccu9DFofQxaK6bvu9Bjk708-x-2M7h_olP4bf7qPDfFmslnE20oD5hsHfKeN-z9CYOWxV2ArMt9N-BCBlu1S-H_e_wF39CogA</recordid><startdate>19920701</startdate><enddate>19920701</enddate><creator>Kario, Kazuomi</creator><creator>Matsuo, Takefumi</creator><creator>Tai, Shigeru</creator><creator>Sakamoto, Susumu</creator><creator>Yamada, Tsutomu</creator><creator>Miki, Takahiko</creator><creator>Matsuo, Miyako</creator><general>Elsevier Ltd</general><general>Elsevier Science</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19920701</creationdate><title>Congenital protein c deficiency and myocardial infarction: Concomitant factor VII hyperactivity may play a role in the onset of arterial thrombosis</title><author>Kario, Kazuomi ; Matsuo, Takefumi ; Tai, Shigeru ; Sakamoto, Susumu ; Yamada, Tsutomu ; Miki, Takahiko ; Matsuo, Miyako</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c452t-485d76f522d9f77b3dcfdc9424f42594ce0099e9e4f33a872e9aebe5de69ff693</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1992</creationdate><topic>Acute myocardial infarction</topic><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Aspirin - therapeutic use</topic><topic>Biological and medical sciences</topic><topic>Blood Coagulation Factors - analysis</topic><topic>Congenital protein C deficiency</topic><topic>Factor VII - analysis</topic><topic>Factor VII hyperactivity</topic><topic>Hematology</topic><topic>Humans</topic><topic>Investigative techniques, diagnostic techniques (general aspects)</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Myocardial Infarction - blood</topic><topic>Myocardial Infarction - drug therapy</topic><topic>Myocardial Infarction - etiology</topic><topic>Pathology. Cytology. Biochemistry. Spectrometry. Miscellaneous investigative techniques</topic><topic>Pedigree</topic><topic>Plasma thrombomodulin level</topic><topic>Protein C Deficiency</topic><topic>Prothrombin Time</topic><topic>Risk Factors</topic><topic>Thrombosis - etiology</topic><topic>Tissue Plasminogen Activator - therapeutic use</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kario, Kazuomi</creatorcontrib><creatorcontrib>Matsuo, Takefumi</creatorcontrib><creatorcontrib>Tai, Shigeru</creatorcontrib><creatorcontrib>Sakamoto, Susumu</creatorcontrib><creatorcontrib>Yamada, Tsutomu</creatorcontrib><creatorcontrib>Miki, Takahiko</creatorcontrib><creatorcontrib>Matsuo, Miyako</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Thrombosis research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kario, Kazuomi</au><au>Matsuo, Takefumi</au><au>Tai, Shigeru</au><au>Sakamoto, Susumu</au><au>Yamada, Tsutomu</au><au>Miki, Takahiko</au><au>Matsuo, Miyako</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Congenital protein c deficiency and myocardial infarction: Concomitant factor VII hyperactivity may play a role in the onset of arterial thrombosis</atitle><jtitle>Thrombosis research</jtitle><addtitle>Thromb Res</addtitle><date>1992-07-01</date><risdate>1992</risdate><volume>67</volume><issue>1</issue><spage>95</spage><epage>103</epage><pages>95-103</pages><issn>0049-3848</issn><eissn>1879-2472</eissn><coden>THBRAA</coden><abstract>A 29-year-old man with congenital protein C deficiency and acute myocardial infarction is reported. Four hours after the onset of chest pain, he was treated intravenously with tissue-type plasminogen activator. Subsequent coronary angiography revealed only slight stenosis of the left anterior descending coronary artery without any atherosclerosis. The propositus, his brother, and his mother, showed low levels of both protein C activity and antigen, while plasma thrombomodulin levels were normal. His grandfather had died from acute myocardial infarction at 38 years of age. We investigated several other risk factors for arterial thrombosis, including factor VII, fibrinogen, heparin cofactor II, lipoprotein (a), and anticardiolipin antibodies. No other haemostatic abnormalities apart from factor VI hyperactivity were detected in this family. To study the effects of protein C and factor VI on procoagulant activity, prothrombin time was measured after the addition of activated protein C and factor VI to protein C-deficient plasma. The prothrombin time ratio decreased along with an increase in the factor VII level. It also decreased with a decrease in the activated protein C level. These findings indicated that the procoagulant activity of factor VI was enhanced by low protein C levels, suggesting that concomitant factor VII hyper-activity may cause acute myocardial infarction in patients with protein C deficiency.</abstract><cop>New York, NY</cop><pub>Elsevier Ltd</pub><pmid>1440517</pmid><doi>10.1016/0049-3848(92)90261-8</doi><tpages>9</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0049-3848 |
ispartof | Thrombosis research, 1992-07, Vol.67 (1), p.95-103 |
issn | 0049-3848 1879-2472 |
language | eng |
recordid | cdi_pubmed_primary_1440517 |
source | MEDLINE; ScienceDirect Journals (5 years ago - present) |
subjects | Acute myocardial infarction Adult Aged Aged, 80 and over Aspirin - therapeutic use Biological and medical sciences Blood Coagulation Factors - analysis Congenital protein C deficiency Factor VII - analysis Factor VII hyperactivity Hematology Humans Investigative techniques, diagnostic techniques (general aspects) Male Medical sciences Middle Aged Myocardial Infarction - blood Myocardial Infarction - drug therapy Myocardial Infarction - etiology Pathology. Cytology. Biochemistry. Spectrometry. Miscellaneous investigative techniques Pedigree Plasma thrombomodulin level Protein C Deficiency Prothrombin Time Risk Factors Thrombosis - etiology Tissue Plasminogen Activator - therapeutic use |
title | Congenital protein c deficiency and myocardial infarction: Concomitant factor VII hyperactivity may play a role in the onset of arterial thrombosis |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T00%3A21%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Congenital%20protein%20c%20deficiency%20and%20myocardial%20infarction:%20Concomitant%20factor%20VII%20hyperactivity%20may%20play%20a%20role%20in%20the%20onset%20of%20arterial%20thrombosis&rft.jtitle=Thrombosis%20research&rft.au=Kario,%20Kazuomi&rft.date=1992-07-01&rft.volume=67&rft.issue=1&rft.spage=95&rft.epage=103&rft.pages=95-103&rft.issn=0049-3848&rft.eissn=1879-2472&rft.coden=THBRAA&rft_id=info:doi/10.1016/0049-3848(92)90261-8&rft_dat=%3Cproquest_cross%3E73332155%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=73332155&rft_id=info:pmid/1440517&rft_els_id=0049384892902618&rfr_iscdi=true |